A role for CYP in the drughormone crosstalk of the brain

Expert Opinion on Drug Metabolism and Toxicology

Volumn 6, Issue 6, 2010, Pages 675-687

  Meyer, Ralf Peter ^a   Gehlhaus, Marcel ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Androgen receptor; Brain; CYP; Drug metabolism; Drughormone crosstalk; Endocrine signaling; Neuroactive drug; Steroid hormone; Steroid hormone receptor; Testosterone

Indexed keywords

ANDROSTANOLONE; ANTICONVULSIVE AGENT; CYTARABINE; CYTOCHROME; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; CYTOCHROME P450 1B1; CYTOCHROME P450 2B1; CYTOCHROME P450 2B10; CYTOCHROME P450 2C11; CYTOCHROME P450 2C29; CYTOCHROME P450 2D1; CYTOCHROME P450 2D4; CYTOCHROME P450 2D6; CYTOCHROME P450 2D7; CYTOCHROME P450 2E1; CYTOCHROME P450 2G; CYTOCHROME P450 3A11; CYTOCHROME P450 3A13; CYTOCHROME P450 3A4; CYTOCHROME P450 3A9; CYTOCHROME P450 4F; ESTRADIOL; METHOTREXATE; NEUROLEPTIC AGENT; TESTOSTERONE; UNCLASSIFIED DRUG; CYTOCHROME P450; DRUG; SEX HORMONE;

AMYGDALOID NUCLEUS; ANXIETY DISORDER; BLOOD BRAIN BARRIER; BRAIN LYMPHOMA; BRAIN REGION; BRAIN TISSUE; BRAIN TUMOR; BREAST CANCER; CEREBELLUM; COGNITION; DEGENERATIVE DISEASE; DEMENTIA; DEPRESSION; DRUG HORMONE INTERACTION; DRUG MEGADOSE; DRUG METABOLISM; DRUG PENETRATION; DRUG POTENCY; DRUG PROTEIN BINDING; ENZYME ACTIVITY; EPILEPSY; GLIOMA; HIPPOCAMPUS; HORMONE ACTION; HUMAN; HYPOTHALAMUS; LONG TERM CARE; LYMPHOMA; NEUROLOGIC DISEASE; NONHUMAN; PROTEIN LOCALIZATION; REVIEW; SCHIZOPHRENIA; SIDE EFFECT; ANIMAL; BRAIN; ENZYMOLOGY; METABOLISM;

ANIMALS; BRAIN; CYTOCHROME P-450 ENZYME SYSTEM; GONADAL STEROID HORMONES; HUMANS; PHARMACEUTICAL PREPARATIONS;

EID: 77952513532     PISSN: 17425255     EISSN: None     Source Type: Journal    
DOI: 10.1517/17425251003680791     Document Type: Review

References (130)

1. Meyer RP, Gehlhaus M, Knoth R, Volk B. Expression and function of cytochrome P450 in brain drug metabolism. Curr Drug Metab 2007;8(4):297-306 •• A concise review on brain P450 expression and function.
2. Kold B, Whishaw JQ, Atkinson RA, et al. Fundamentals of human neuropsychology. Worth Publishers, New York; 1996
3. Barker CF, Billingham RE. Immunologically privileged sites. Adv Immunol 1977;25:1-54
4. Arck PC, Gilhar A, Bienenstock J, Paus R. The alchemy of immune privilege explored from a neuroimmunological perspective. Curr Opin Pharmacol 2008;8(4):480-9
5. Rolls A, Shechter R, Schwartz M. The bright side of the glial scar in CNS repair. Nat Rev Neurosci 2009;10(3):235-41
6. Dantzer R, O'Connor JC, Freund GG, et al. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 2008;9(1):46-56
7. Ingelman-Sundberg M. Human drug metabolising cytochrome P450 enzymes: properties and polymorphisms. Naunyn Schmiedebergs Arch Pharmacol 2004;369(1):89-104
8. Wilkinson GR. Drug metabolism and variability among patients in drug response. N Engl J Med 2005;352(21):2211-21
9. Bermejo I, Kratz S, Gaebel W, et al. Self-evaluation of depression by patients and condition identification by primary care physicians-a comparison. Med Welt 2005;56(3):73-8
10. Jahrbuch S, Deutsche Hauptstelle fuer Suchtfrage, (Editor), Jahrbuch sucht (2004). Neuland Verlag, Geesthacht, Germany
11. Wittchen HU, Jacobi F. Angststoerungen. Gesundheitsberichterstattung desBundes. Robert Koch-Institut. Berlin, Germany; 2004. p. 1-16
12. Forsgren L, Beghi E, Oun A, Sillanpaa M. The epidemiology of epilepsy in Europe-a systematic review. Eur J Neurol 2005;12(4):245-53
13. Prilipko L, deBoer HM, Saxena S, WHO. Atlas: epilepsy care in the world. World Health Organisation, Geneva, Switzerland; 2005
14. Newton HB. Marrow ablative chemotherapy with hematopoetic stem cell rescue. In: Newton HB, editor, Handbook of brain tumor chemotherapy. Academic Press, Oxford; 2005. p. 305-15
15. Newton HB. Clinical pharmacology of brain tumor chemotherapy. In: Newton HB, editor, Handbook of brain tumor chemotherapy. Academic Press, Oxford; 2005. p. 21-42
16. Borges MM, Paula-Barbosa MM, Volk B. Chronic alcohol consumption induces lipofuscin deposition in the rat hippocampus. Neurobiol Aging 1986;7(5):347-55
17. Lundqvist C, Volk B, Knoth R, Alling C. Long-term effects of intermittent versus continuous ethanol exposure on hippocampal synapses of the rat. Acta Neuropathol 1994;87(3):242-9
18. Schoedel KA, Tyndale RF. Induction of nicotine-metabolizing CYP2B1 by ethanol and ethanol-metabolizing CYP2E1 by nicotine: summary and implications. Biochim Biophys Acta 2003;1619(3):283-90
19. Room R, Babor T, Rehm J. Alcohol and public health. Lancet 2005;365(9458):519-30
20. Correa DD, Ahles TA. Neurocognitive changes in cancer survivors. Cancer J 2008;14(6):396-400
21. Sun W, Wang W, Wu X, Wang Y. Antiepileptic drugs and the significance of event-related potentials. J Clin Neurophysiol 2007;24(3):271-6
22. Isojarvi JI, Tauboll E, Herzog AG. Effect of antiepileptic drugs on reproductive endocrine function in individuals with epilepsy. CNS Drugs 2005;19(3):207-23 •• A concise summary of the endocrine disorders in patients taking P450-inducing drugs. (Pubitemid 40460661)
23. Herzog AG. Altered reproductive endocrine regulation in men with epilepsy: implications for reproductive function and seizures. Ann Neurol 2002;51(5):539-42
24. Meyer RP, Hagemeyer CE, Knoth R, et al. Anti-epileptic drug phenytoin enhances androgen metabolism and androgen receptor expression in murine hippocampus. J Neurochem 2006;96(2):460-72
25. Molleken D, Richter-Appelt H, Stodieck S, Bengner T. Sexual quality of life in epilepsy: correlations with sex hormone blood levels. Epilepsy Behav 2009;14(1):226-31
26. Herzog AG. Disorders of reproduction in patients with epilepsy: primary neurological mechanisms. Seizure 2008;17(2):101-10
27. Luef G, Rauchenzauner M. Epilepsy and hormones: a critical review. Epilepsy Behav 2009;15(1):73-7
28. Reddy DS. Role of neurosteroids in catamenial epilepsy. Epilepsy Res 2004;62(2-3):99-118
29. Isojarvi J. Disorders of reproduction in patients with epilepsy: antiepileptic drug related mechanisms. Seizure 2008;17(2):111-9
30. Killer N, Hock M, Gehlhaus M, et al. Modulation of androgen and estrogen receptor expression by antiepileptic drugs and steroids in hippocampus of patients with temporal lobe epilepsy. Epilepsia 2009;50(8):1875-90 •• Demonstrates drug-homone crosstalk (AR, ER and P450) in samples from human brain.
31. Frye CA. Role of androgens in epilepsy. Expert Rev Neurother 2006;6(7):1061-75 •• A concise overview on steroid hormone action and regulation in epilepsy.
32. Flockhart DA. P450-Drug interaction table. Available from: http://medicine. iupui.edu/clinpharm/ddis/. [Last accessed 13 January 2010]
33. Nelson DR. P450 nomenclature and overview. Available from: http://drnelson. utmem.edu/CytochromeP450.html. [Last accessed 14 January 2010]
34. Anakk S, Kalsotra A, Shen Q, et al. Genomic characterization and regulation of CYP3a13: role of xenobiotics and nuclear receptors. FASEB J 2003;17(12):1736-8
35. Handschin C, Meyer UA. Induction of drug metabolism: the role of nuclear receptors. Pharmacol Rev 2003;55(4):649-73
36. Tannock IF, Ahles TA, Ganz PA, Van Dam FS. Cognitive impairment associated with chemotherapy for cancer: report of a workshop. J Clin Oncol 2004;22(11):2233-9
37. Ahles TA, Saykin AJ. Breast cancer chemotherapy-related cognitive dysfunction. Clin Breast Cancer 2002;3(Suppl 3):S84-90
38. Ahles TA, Saykin AJ. Candidate mechanisms for chemotherapy-induced cognitive changes. Nat Rev Cancer 2007;7(3):192-201 •• Gives a good overview on the current discussion concernng mechanisms in CHT induced cogitive changes.
39. Minisini A, Atalay G, Bottomley A, et al. What is the effect of systemic anticancer treatment on cognitive function? Lancet Oncol 2004;5(5):273-82
40. Gervasini G. Polymorphisms in methotrexate pathways: what is clinically relevant, what is not, and what is promising. Curr Drug Metab 2009;10(6):547-66
41. Abbott NJ, Ronnback L, Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 2006;7(1):41-53
42. Bauer B, Hartz AM, Fricker G, Miller DS. Pregnane X receptor up-regulation of P-glycoprotein expression and transport function at the blood-brain barrier. Mol Pharmacol 2004;66(3):413-9
43. Stanley LA, Horsburgh BC, Ross J, et al. Drug transporters: gatekeepers controlling access of xenobiotics to the cellular interior. Drug Metab Rev 2009;41(1):27-65
44. Hennessy M, Kelleher D, Spiers JP, et al. St Johns wort increases expression of P-glycoprotein: implications for drug interactions. Br J Clin Pharmacol 2002;53(1):75-82
45. Ioannides C. Pharmacokinetic interactions between herbal remedies and medicinal drugs. Xenobiotica 2002;32(6):451-78
46. Miksys SL, Tyndale RF. Drug-metabolizing cytochrome P450s in the brain. J Psychiatry Neurosci 2002;27(6):406-15
47. Miksys S, Tyndale RF. Brain drug-metabolizing cytochrome P450 enzymes are active in vivo, demonstrated by mechanism-based enzyme inhibition. Neuropsychopharmacology 2009;34(3):634-40 •• Gives an overview on recent methodology to access brain drug metabolism.
48. Wang Y, Zhao J, Kalsotra A, et al. CYP4Fs expression in rat brain correlates with changes in LTB4 levels after traumatic brain injury. J Neurotrauma 2008;25(10):1187-94
49. Meyer RP, Volk B, Knoth R, et al. Function of astrocyte cytochrome P450 in control of xenobiotic metabolism. The role of glia in neurotoxicity. CRC Press, Boca Raton; 2004. p. 61-72
50. Koehler RC, Roman RJ, Harder DR. Astrocytes and the regulation of cerebral blood flow. Trends Neurosci 2009;32(3):160-9
51. Delaporte E, Renton KW. Cytochrome P4501A1 and cytochrome P4501A2 are downregulated at both transcriptional and post-transcriptional levels by conditions resulting in interferon-alpha/beta induction. J Pharm Biomed Anal 1997;60(10):787-96
52. Tindberg N. Phorbol ester induces CYP2E1 in astrocytes, through a protein kinase C- and tyrosine kinase-dependent mechanism. J Neurochem 2003;86(4):888-95
53. Huang P, Rannug A, Ahlbom E, et al. Effect of 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin on the expression of cytochrome P450 1A1, the aryl hydrocarbon receptor, and the aryl hydrocarbon receptor nuclear translocator in rat brain and pituitary. Toxicol Appl Pharmacol 2000;169(2):159-67
54. Gu J, Zhang QY, Genter MB, et al. Purification and characterization of heterologously expressed mouse CYP2A5 and CYP2G1: role in metabolic activation of acetaminophen and 2, 6-dichlorobenzonitrile in mouse olfactory mucosal microsomes. J Pharm Exp Ther 1998;285(3):1287-95
55. Meyer RP, Podvinec M, Meyer UA. Cytochrome P450 CYP1A1 accumulates in the cytosol of kidney and brain and is activated by heme. Mol Pharmacol 2002;62(5):1061-7 •• Basic paper on the regulation of brain P450 by heme.
56. Schilter B, Omiecinski CJ. Regional distribution and expression modulation of cytochrome P-450 and epoxide hydrolase mRNAs in the rat brain. Mol Pharmacol 1993;44(5):990-6
57. Funae Y, Kishimoto W, Cho T, et al. CYP2D in the brain. Drug Metab Pharmacokinet 2003;18(6):337-49
58. Hiroi T, Kishimoto W, Chow T, et al. Progesterone oxidation by cytochrome P450 2D isoforms in the brain. Endocrinology 2001;142(9):3901-8
59. Kishimoto W, Hiroi T, Shiraishi M, et al. Cytochrome P450 2D catalyze steroid 21-hydroxylation in the brain. Endocrinology 2004;145(2):699-705
60. Hagemeyer CE, Rosenbrock H, Ditter M, et al. Predominantly neuronal expression of cytochrome P450 isoforms CYP3A11 and CYP3A13 in mouse brain. Neuroscience 2003;117(3):521-9
61. Meyer RP, Gehlhaus M, Schwab R, et al. Concordant up-regulation of cytochrome P450 Cyp3a11, testosterone oxidation and androgen receptor expression in mouse brain after xenobiotic treatment. J Neurochem 2009;109(2):670-81
62. Wang H, Napoli KL, Strobel HW. Cytochrome P450 3A9 catalyzes the metabolism of progesterone and other steroid hormones. Mol Cell Biochem 2000;213(1-2):127-35
63. Lee AM, Miksys S, Palmour R, Tyndale RF. CYP2B6 is expressed in African green monkey brain and is induced by chronic nicotine treatment. Neuropharmacology 2006;50(4):441-50
64. Howard LA, Miksys S, Hoffmann E, et al. Brain CYP2E1 is induced by nicotine and ethanol in rat and is higher in smokers and alcoholics. Br J Pharmacol 2003;138(7):1376-86
65. Jover R, Hoffmann K, Meyer UA. Induction of 5-aminolevulinate synthase by drugs is independent of increased apocytochrome P450 synthesis. Biochem Biophys Res Commun 1996;226(1):152-7
66. Maines MD. The heme oxygenase system and its functions in the brain. Cell Mol Biol 2000;46(3):573-85
67. Lindberg RLP, Porcher C, Grandchamp B, et al. Porphobilinogen deaminase deficiency in mice causes a neuropathy resembling that of human hepatic porphyria. Nat Genet 1996;12(2):195-9
68. Meyer RP, Lindberg RL, Hoffmann F, Meyer UA. Cytosolic persistence of mouse brain CYP1A1 in chronic heme deficiency. Biol Chem 2005;386(11):1157-64
69. Omiecinski CJ, Juchau MR. Activators of cytochrome P-450 dependent monooxygenation reactions. Proc West Pharmacol Soc 1980;23:9-10 • One of the first papers demonstrating the heme effect on extrahepatic P450s.
70. Bissell DM, Hammaker LE. Cytochrome P-450 heme and the regulation of hepatic heme oxygenase activity. Arch Biochem Biophys 1976;176(1):91-102
71. Giger U, Meyer UA. Effect of succinylacetone on heme and cytochrome P450 synthesis in hepatocyte culture. FEBS Lett 1983;153(2):335-8
72. Fraser DJ, Zumsteg A, Meyer UA. Nuclear receptors constitutive androstane receptor and pregnane X receptor activate a drug-responsive enhancer of the murine 5-aminolevulinic acid synthase gene. J Biol Chem 2003;278(41):39392-401
73. Reed CJ, van den Broeke LT, De Matteis F. Drug-induced protoporphyria in the olfactory mucosa of the hamster. J Biochem Toxicol 1989;4(3):161-4
74. De Matteis F, Zetterlund P, Wetterberg L. Brain 5-aminolaevulinate synthase. Developmental aspects and evidence for regulatory role. Biochem J 1981;196(3):811-7
75. Ingi T, Chiang G, Ronnett GV. The regulation of heme turnover and carbon monoxide biosynthesis in cultured primary rat olfactory receptor neurons. J Neurosci 1996;16(18):5621-8
76. Jover R, Hoffmann F, Scheffler-Koch V, Lindberg RL. Limited heme synthesis in porphobilinogen deaminase-deficient mice impairs transcriptional activation of specific cytochrome P450 genes by phenobarbital. Eur J Biochem 2000;267(24):7128-37
77. da Silva JL, Zand BA, Yang LM, et al. Heme oxygenase isoformspecific expression and distribution in the rat kidney. Kidney Int 2001;59(4):1448-57
78. Meier PJ, Gasser R, Hauri HP, et al. Biosynthesis of rat liver cytochrome P-450 in mitochondria-associated rough endoplasmic reticulum and in rough microsomes in vivo. J Biol Chem 1984;259(16):10194-200
79. De Matteis F, Marks GS. Cytochrome P450 and its interactions with the heme biosynthetic pathway. Can J Physiol Pharmacol 1996;74(1):1-8
80. Szczesna-Skorupa E, Kemper B. Influence of protein-protein interactions on the cellular localization of cytochrome P450. Expert Opin Drug Metab Toxicol 2008;4(2):123-36
81. Szczesna-Skorupa E, Kemper B. Proteasome inhibition compromises direct retention of cytochrome P450 2C2 in the endoplasmic reticulum. Exp Cell Res 2008;314(17):3221-31
82. Hagemeyer CE, Burck C, Schwab R, et al. 7-Benzyloxyresorufin-O-dealkylase activity as a marker for measuring cytochrome P450 CYP3A induction in mouse liver. Anal Biochem 2010;398(1):104-11
83. Kommaddi RP, Turman CM, Moorthy B, et al. An alternatively spliced cytochrome P4501A1 in human brain fails to bioactivate polycyclic aromatic hydrocarbons to DNA-reactive metabolites. J Neurochem 2007;102(3):867-77
84. Ravindranath V, Kommaddi RP, Pai HV. Unique cytochromes P450 in human brain: implication in disease pathogenesis. J Neural Transm Suppl 2006;70:167-71
85. Pai HV, Kommaddi RP, Chinta SJ, et al. A frameshift mutation and alternate splicing in human brain generate a functional form of the pseudogene cytochrome P4502D7 that demethylates codeine to morphine. J Biol Chem 2004;279(26):27383-9
86. Yue J, Khokhar J, Miksys S, Tyndale RF. Differential induction of ethanol-metabolizing CYP2E1 and nicotine-metabolizing CYP2B1/2 in rat liver by chronic nicotine treatment and voluntary ethanol intake. Eur J Pharmacol 2009;609(1-3):88-95
87. Miksys SL, Cheung C, Gonzalez FJ, Tyndale RF. Human CYP2D6 and mouse CYP2Ds: organ distribution in a humanized mouse model. Drug Metab Dispos 2005;33(10):1495-502
88. Joshi M, Tyndale RF. Regional and cellular distribution of CYP2E1 in monkey brain and its induction by chronic nicotine. Neuropharmacology 2006;50(5):568-75
89. Miksys S, Lerman C, Shields PG, et al. Smoking, alcoholism and genetic polymorphisms alter CYP2B6 levels in human brain. Neuropharmacology 2003;45(1):122-32
90. Ingelman-Sundberg M. Pharmacogenetics of cytochrome P450 and its applications in drug therapy: the past, present and future. Trends Pharmacol Sci 2004;25(4):193-200
91. Warner M, Gustafsson JA. Cytochrome P450 in the brain: neuroendocrine functions. Frontiers Neuroendocrinol 1995;16:224-36
92. Hedlund E, Gustafsson JA, Warner M. Cytochrome P450 in the brain; a review. Curr Drug Metab 2001;2(3):245-63
93. Wojcikowski J, Golembiowska K, Daniel WA. The regulation of liver cytochrome p450 by the brain dopaminergic system. Curr Drug Metab 2007;8(6):631-8
94. Wojcikowski J, Daniel WA. The brain dopaminergic system as an important center regulating liver cytochrome P450 in the rat. Expert Opin Drug Metab Toxicol 2009;5(6):631-45
95. Gervasini G, Carrillo JA, Benitez J. Potential role of cerebral cytochrome P450 in clinical pharmacokinetics: modulation by endogenous compounds. Clin Pharmacokinet 2004;43(11):693-706
96. Berkovic SF. Treatment with anti-epileptic drugs. Aust Fam Physician 2005;34(12):1017-20
97. Rogawski MA, Loscher W. The neurobiology of antiepileptic drugs. Nat Rev Neurosci 2004;5(7):553-64
98. Voigt JP, Morgenstern E. Comparative effects of carbamazepine, phenytoin, diazepam and clonazepam on inhibitory avoidance learning in mice. Psychopharmacology 1992;108(1-2):131-5
99. Gehlhaus M, Schmitt N, Volk B, Meyer RP. Antiepileptic drugs affect neuronal androgen signaling via a cytochrome P450-dependent pathway. J Pharm Exp Ther 2007;322(2):550-9 •• Mechanistic aspects of the drug hormone crosstalk.
100. Frye CA. Hormonal influences on seizures: basic neurobiology. Int Rev Neurobiol 2008;83:27-77
101. Quarmby VE, Yarbrough WG, Lubahn DB, et al. Autologous down-regulation of androgen receptor messenger ribonucleic acid. Mol Endocrinol 1990;4(1):22-8
102. Krongrad A, Wilson CM, Wilson JD, et al. Androgen increases androgen receptor protein while decreasing receptor mRNA in LNCaP cells. Mol Cell Endocrinol 1991;76(1-3):79-88
103. Kumar RC, Thakur MK. Androgen receptor mRNA is inversely regulated by testosterone and estradiol in adult mouse brain. Neurobiol Aging 2004;25(7):925-33
104. Peper M, Herpers M, Spreer J, et al. Functional neuroimaging of emotional learning and autonomic reactions. J Physiol Paris 2006;99(4-6):342-54
105. Bauer B, Yang X, Hartz AM, et al. In vivo activation of human pregnane X receptor tightens the blood-brain barrier to methadone through P-glycoprotein up-regulation. Mol Pharmacol 2006;70(4):1212-9
106. Anakk S, Kalsotra A, Kikuta Y, et al. CAR/PXR provide directives for Cyp3a41 gene regulation differently from Cyp3a11. Pharmacogenomics J 2004;4(2):91-101
107. Iba MM, Storch A, Ghosal A, et al. Constitutive and inducible levels of CYP1A1 and CYP1A2 in rat cerebral cortex and cerebellum. ArchToxicol 2003;77(10):547-54
108. Barnett JA, Urbauer DL, Murray GI, et al. Cytochrome P450 1B1 expression in glial cell tumors: an immunotherapeutic target. Clin Cancer Res 2007;13(12):3559-67
109. Rieder CR, Parsons RB, Fitch NJ, et al. Human brain cytochrome P450 1B1: immunohistochemical localization in human temporal lobe and induction by dimethylbenz (a) anthracene in astrocytoma cell line (MOG-G-CCM). Neurosci Lett 2000;278(3):177-80
110. Miksys S, Rao Y, Sellers EM, et al. Regional and cellular distribution of CYP2D subfamily members in rat brain. Xenobiotica 2000;30(6):547-64
111. Volk B, Meyer RP, von Lintig F, et al. Localization and characterization of cytochrome P450 in the brain. In vivo and in vitro investigations on phenytoin- and phenobarbital-inducible isoforms. Toxicol Lett 1995;83:655-62
112. Thuerl C, Otten U, Knoth R, et al. Possible role of cytochrome P450 in inactivation of testosterone in immortalized hippocampal neurons. Brain Res 1997;762(1-2):47-55
113. Meyer RP, Knoth R, Schiltz E, Volk B. Possible function of astrocyte cytochrome P450 in control of xenobiotic phenytoin in the brain: in vitro studies on murine astrocyte primary cultures. Exp Neurol 2001;167(2):376-84
114. Tyndale RF, Li Y, Li NY, et al. Characterization of cytochrome P-450 2D1 activity in rat brain: high-affinity kinetics for dextromethorphan. Drug Metab Dispos 1999;27(8):924-30
115. Hedlund E, Wyss A, Kainu T, et al. Cytochrome P4502D4 in the brain: specific neuronal regulation by clozapine and toluene. Mol Pharm 1996;50:342-50
116. Siegle I, Fritz P, Eckhardt K, et al. Cellular localization and regional distribution of CYP2D6 mRNA and protein expression in human brain. Pharmacogenetics 2001;11(3):237-45
117. Warner M, Gustafsson JA. Effect of ethanol on cytochrome P450 in the rat brain. Proc Natl Acad Sci USA 1994;91(3):1019-23
118. Nef P, Heldman J, Lazard D, et al. Olfactory-specific cytochrome P-450. cDNA cloning of a novel neuroepithelial enzyme possibly involved in chemoreception. J Biol Chem 1989;264:6780-5
119. Voirol P, Jonzier-Perey M, Porchet F, et al. Cytochrome P-450 activities in human and rat brain microsomes. Brain Res 2000;855(2):235-43
120. Wang H, Strobel HW. Regulation of CYP3A9 gene expression by estrogen and catalytic studies using cytochrome P450 3A9 expressed in Escherichia coli. Arch Biochem Biophys 1997;344(2):365-72
121. Wang H, Kawashima H, Strobel HW. cDNA cloning of a novel CYP3A from rat brain. Biochem Biophys Res Commun 1996;221(1):157-62
122. Stromstedt M, Warner M, Gustafsson JA. Cytochrome P450s of the 4A subfamily in the brain. J Neurochem 1994;63(2):671-6
123. Kawashima H, Strobel HW. cDNA cloning of three new forms of rat brain cytochrome P450 belonging to the CYP4F subfamily. Biochem Biophys Res Commun 1995;217(3):1137-44
124. Stark K, Dostalek M, Guengerich FP. Expression and purification of orphan cytochrome P450 4X1 and oxidation of anandamide. FEBS J 2008;275(14):3706-17
125. Bylund J, Zhang C, Harder DR. Identification of a novel cytochrome P450, CYP4X1, with unique localization specific to the brain. Biochem Biophys Res Commun 2002;296(3):677-84
126. Al Anizy M, Horley NJ, Kuo CW, et al. Cytochrome P450 Cyp4x1 is a major P450 protein in mouse brain. FEBS J 2006;273(5):936-47
127. Pringle AK, Schmidt W, Deans JK, et al. 7-Hydroxylated epiandrosterone (7-OH-EPIA) reduces ischaemia-induced neuronal damage both in vivo and in vitro. Eur J Neurosci 2003;18(1):117-24
128. Yau JL, Rasmuson S, Andrew R, et al. Dehydroepiandrosterone 7-hydroxylase CYP7B: predominant expression in primate hippocampus and reduced expression in Alzheimer's disease. Neuroscience 2003;121(2):307-14
129. Rose KA, Stapleton G, Dott K, et al. Cyp7b, a novel brain cytochrome P450, catalyzes the synthesis of neurosteroids 7alpha-hydroxy dehydroepiandrosterone and 7alpha-hydroxy pregnenolone. Proc Natl Acad Sci USA 1997;94(10):4925-30
130. Herzog AG, Fowler KM. Sexual hormones and epilepsy: threat and opportunities. Curr Opin Neurol 2005;18(2):167-72